Study of GX-I7 in Combination With Pembrolizumab in Refractory or Relapsed (R/R) TNBC Subjects(GX-I7-CA-006/KEYNOTE-899)
Clinical trial NCT03752723 · COMPLETED
Trial details
- NCT number
- NCT03752723
- Sponsor
- Genexine, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-27
- Primary completion
- 2023-05-11
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.